Provider

Under the banner of the Consumer Technology Association, the companies hope that clear standards will improve digital therapeutics adoption and implementation.

The company released three new products today that are available today for preorder on Fitbit’s website and will be sold worldwide in late September.

The app will facilitate the exchange of crucial information such as X-rays and guidance to ensure orthopaedic injuries get treatment in an appropriate time frame.

Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.

After her daughter's PFIC diagnosis, Claire Brinkley searched for a way to connect with other parents with similar experiences and questions. 

The offerings, aimed at improving patient communication, have been developed by intelligent commerce and customer service software provider, Novomind MEA.

The Abu Dhabi-based company is reportedly in talks to co-develop a COVID-19 test that can detect positive cases of the coronavirus from exhaled nasal air.

The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs.

Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.

The patient-facing EASE app is HIPAA compliant, and does not save any texts, photos or videos to the recipient's device.